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           In a neutrophil-dependent arthritis elicited by 
injections of a mixture of anti  –  type II colla-
gen mAbs followed by LPS, mice lacking the 
tyrosine-based inhibitory receptor leukocyte Ig-
like receptor B4 (LILRB4) have an exacerbated 
clinical response characterized morphologically 
by greater synovial thickening with neutrophil 
infi  ltration and depletion of articular cartilage 
matrix with erosions, compared with   Lilrb4        +       
mice (  1  ). LILRB4 is expressed on and regulates 
pathobiologic functions of neutrophils in a vas-
culopathy model (  2  ) and mast cells in anaphylaxis 
(  3  ). Neutrophil infi  ltration in the arthritis model 
was greater in the aff  ected joints of LILRB4 
null (  Lilrb4          −       ) mice compared with   Lilrb4        +       mice, 
whereas the number and degranulation of sy-
novial mast cells was not diff  erent in the two 
strains. However, the fi  nding that   Lilrb4          −        mice 
generate greater amounts of IL-1    , macrophage 
infl  ammatory protein 1    , and macrophage in-
fl  ammatory protein 2 in the infl  amed joints (  1  ), 
each of which contributes to the tissue injury in 
this model, raises the possibility that mast cells 
might participate in a manner not revealed by 
numbers or degranulation, particularly because 
mast cells provide IL-1     during the initiating 
phase of infl  ammatory arthritis induced by injec-
tion of antibodies (Abs) to glucose 6-phosphate 
isomerase (GPI) (  4  ). In the latter model, mast 
cell  –  defi  cient   Kit        W        /Kit        W-v       mice do not develop 
arthritis but are rendered susceptible by adop-
tive transfer of BM-derived mast cells from IL-
1      +   mice, but not from IL-1        −    mice. 
  We report here the unexpected fi  nding that 
  Kit        W-sh       but not   Kit        W        /Kit        W-v       mice undergo full 
clinical and histologic arthritis induced by mAbs 
to type II collagen and LPS as compared with 
their respective   Kit        +       strains. Both strains are pro-
foundly mast cell defi  cient and fail to exhibit 
mast cell  –  dependent hypersensitivity reactions. 
  Kit        W        /Kit        W-v       but not   Kit        W-sh       mice had a basal 
neutropenia and defi  cient LPS-elicited neutro-
philia, suggesting that the relative neutrophil 
defi  ciency in the   Kit        W        /Kit        W-v       strain may per-
mit phenotypic complementation by mast cells. 
Anti-collagen/LPS-induced joint swelling was 
exacerbated in the absence of LILRB4 in the 
  Kit        W-sh       strain and was neutrophil dependent in 
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  We previously reported that joint swelling, synovial thickening, and cartilage matrix deple-
tion induced by the injection of anti-collagen monoclonal antibodies and lipopolysaccharide 
(LPS) in BALB/c mice are increased in the absence of inhibitory leukocyte immunoglobulin 
(Ig)-like receptor B4 (LILRB4; formerly gp49B1) in a neutrophil-dependent manner. Be-
cause both mast cells and neutrophils express LILRB4, we sought a mast cell requirement 
with mast cell  –  defi  cient mouse strains, but unexpectedly obtained full arthritis in   Kit            W-sh          
mice and full resistance in   Kit                  W  /Kit  W-v                mice.   Kit            W-sh          mice were indeed mast cell defi  cient as 
assessed by histology and the absence of IgE/mast cell  –  dependent passive cutaneous ana-
phylaxis in the ear and joint as well as passive systemic anaphylaxis. Deletion of LILRB4 in 
  Kit            W-sh          mice exacerbated anti-collagen/LPS-induced joint swelling that was abolished by 
neutrophil depletion, establishing a counterregulatory role for LILRB4 in the absence of 
mast cells. Whereas blood neutrophil levels and LPS-elicited tissue neutrophilia were equal 
in   Kit            W-sh          and   Kit                  +    mice, both were impaired in   Kit                  W  /Kit  W-v                mice. Although both strains are 
mast cell defi  cient and protected from IgE-mediated anaphylactic reactions, their dramati-
cally different responses to autoantibody-mediated, neutrophil-dependent immune complex 
arthritis suggest that other host differences determine the extent of mast cell involvement. 
Thus, a conclusion for an absolute mast cell role in a pathobiologic process requires evi-
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contribution based on studies reported in mast cell  –  defi  cient 
  Kit  W  /Kit  W-V     mice in the arthritis model induced with anti-GPI 
Abs (  5  ), we evaluated our protocol in that strain and its   Kit  +     
control. When WBB6F1-  Kit  +     mice were injected with 4 mg 
of anti-collagen and either 25 or 50     g LPS, they developed 
joint swelling on day 5 and attained maximal clinical scores of 
5 and 6.8, respectively, by day 7, whereas mast cell  –  defi  cient 
  Kit  W  /Kit  W-v     mice did not exhibit joint swelling (  Fig. 1 B  ). 
  Histologic and functional evidence of mast cell defi  ciency 
in   Kit  W-sh     mice 
  We confi  rmed that our   Kit  W-sh     mice were mast cell defi  cient 
by histologic and functional criteria at the age range at which 
arthritis was induced. As determined in tissue sections stained 
for chloroacetate esterase (CAE) activity, there were essen-
tially no mast cells in the synovium and subsynovium of the 
ankle joint, tongue, spleen, liver, kidney, heart, or intestine of 
5  –  9-wk-old naive   Kit  W-sh     mice, and the number of mast cells 
in the ear skin and the dermis adjacent to the subsynovium 
of the ankle joint was 1.7 and 3.4%, respectively, of the 
number in   Kit  +     mice (  n   = 4  –  7). Estimates of the number of 
mast cells in the ear and back skin of 10-wk-old   Kit  W-sh     mice 
have ranged from 6  –  10% of that of   Kit  +     mice, as assessed by 
alcian blue (  6  ) or toluidine blue staining (  7  ) of tissue sections, 
to not detectable in the ear skin by methylene blue staining 
or CAE activity (  8  ).   Kit  +     but not   Kit  W-sh     mice exhibited pas-
sive cutaneous anaphylaxis (PCA) reactions in the ear and 
paw as measured by extravasation of Evans Blue dye-bearing 
protein (  Fig. 2  ), indicating that the   Kit  W-sh     mice are function-
ally defi  cient in dermal mast cells.   Finally, to exclude a pool 
of functional mast cells at any site, we subjected   Kit  W-sh     and 
  Kit  +     mice to passive systemic anaphylaxis induced by i.v. 
  injection of anti  –  mouse IgE. Four out of four   Kit  +     mice 
became moribund, whereas there was no clinical response in 
four out of four   Kit  W-sh     mice. Thus, the   Kit  W-sh     strain is indis-
tinguishable from the   Kit  W  /Kit  W-v     strain with regard to mast 
both   Lilrb4        +       and   Lilrb4          −        mice in the   Kit        W-sh       background. The 
ability to detect an eff  ect of mast cell defi  ciency in   Kit        W        /Kit        W-v       
mice but not   Kit        W-sh       mice suggests that conclusions about abso-
lute mast cell dependence in multicomponent disease models 
such as mAb-mediated arthritis require confi  rmation in a mouse 
strain that is suffi   cient for the other key cellular elements. 
    RESULTS AND DISCUSSION   
  Mast cell defi  ciency in   Kit  W-sh     mice does not prevent 
anti-collagen/LPS-induced arthritis 
  When   Kit  W-sh     mice and mast cell  –  suffi   cient   Kit  +     mice were 
  injected with 2 mg of anti-collagen and 25     g LPS 3 d later, 
joint swelling was detected in both strains on day 5, was maxi-
mal by day 6 with clinical scores of 9, and diminished to the 
baseline level by day 14 (  Fig. 1 A  ).   Furthermore, there were no 
signifi  cant diff  erences in   Kit  +     and   Kit  W-sh     mice at day 7 in syno-
vial thickness, cartilage matrix depletion, and synovial neutro-
philia in ankle joints as assessed histologically (55   ±   5.4 vs. 
52.7   ±   6.1   μ  m, 22.6   ±   2.2 vs. 17.0   ±   2.8% depletion, and 
19.0   ±   6.1 vs. 21.2   ±   7.4 neutrophils/unit area; P = 0.8, 0.1, 
and 0.8, respectively;   n   = 9). Induction of less joint swelling by 
reducing the anti-collagen dose to 0.5 mg resulted in peak 
clinical scores on day 7 in   Kit  +     and   Kit  W-sh     mice of 2.3   ±   0.9 
and 2.7   ±   0.9 (  n   = 3; P = 0.8), respectively, indicating that no 
eff  ect of mast cell defi  ciency was uncovered even at the lower 
limit of clinical detection. Because we had expected a mast cell 
  Figure 1.     Anti-collagen/LPS-induced joint swelling in   Kit  W-sh    and 
  Kit  W /Kit  W-v    mice and their respective WT strains. Mice were injected i.v. 
with 2 mg of a mixture of four anti-collagen mAbs on day 0 and i.p. with 
25 (A and B) or 50 (B)     g LPS on day 3. A score refl  ecting visual assess-
ment of joint swelling in the paw, wrist, and ankle (described in Materials 
and methods) of each leg was assigned, and the four scores for each 
mouse were summed to yield the clinical score. Data are expressed as 
mean   ±   SEM;   n   = 6 from two experiments (days 0  –  7),   n   = 3 from one 
experiment (days 8  –  14) (A),   n   = 4 from one experiment with 25   μ  g LPS, 
and   n   = 4 from one experiment with 50   μ  g LPS (B).     
  Figure 2.     IgE-PCA in mast cell  –  defi  cient and   –  suffi  cient mice. 
Mice were injected i.d. in one ear or s.c. in one paw with 25 and 75 ng of 
mouse monoclonal IgE anti-DNP, respectively, and were injected in the 
other ear or paw with saline. After 20 h, the mice were injected i.v. with 
100     g DNP-HSA/1% Evans blue. After 0.5 h, mice were killed, their ears and 
paws were excised, and the Evans blue was extracted with formamide and 
quantifi  ed by spectrophotometry. Data are expressed as mean   ±   SEM;   n   = 
7  –  9 from two experiments (ear) and   n   = 5 from three experiments (paw).     JEM VOL. 204, November 26, 2007  2799
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  signifi  cantly lower 31% of that of WBB6F1-  Kit  +     mice, and 
reached     80% of normal at 6 mo. The number of BM neu-
trophils in   Kit  W  /Kit  W-v     mice was a signifi  cantly lower 52  –  64% 
of that of WBB6F1-  Kit  +     mice from 3 to 6 mo of age. Even in 
older   Kit  W  /Kit  W-v     mice with near normal peripheral blood 
neutrophil levels, the increase in neutrophils 6 h after i.p. in-
jection of 5   μ  g LPS was only     60% of that of WBB6F1-  Kit  +     
mice (  13  ). Naive   Kitl  Sl    /  Kitl  Sl-d     mice that are on the WCB6F1 
background and are stem cell factor defi  cient (  14  ) also have a 
BM and peripheral blood neutropenia (  15  ). 
  In contrast with   Kit  W  /Kit  W-v     mice, the concentration of neu-
trophils in the blood of naive 7  –  9-wk-old   Kit  W-sh     mice was not 
diff  erent than that of   Kit  +     controls (  Fig. 3  ). Injection of 25   μ  g 
LPS i.p. induced comparable increases in the concentration of 
peripheral blood neutrophils after 24 h in   Kit  +     and   Kit  W-sh     
mice, respectively (  Fig. 3  ). 24 h after i.d. injection of 50   μ  g 
LPS, there was no signifi  cant diff  erence in the number of neu-
trophils in the blood of   Kit  +     and   Kit  W-sh     mice (2.0   ±   0.21 vs. 
1.9   ±   0.21   ×   10  3   cells per   μ  l, respectively;   n   = 3  –  4) or migra-
tion of neutrophils into the ears (13.9   ±   1.2 vs. 12.2   ±   3.5 
neutrophils per unit length, respectively;   n   = 6  –  8; P = 0.7). 
Hence, unlike   Kit  W  /Kit  W-v     mice,   Kit  W-sh     mice exhibit the same 
constitutive blood level and LPS-induced tissue recruitment 
of neutrophils as their   Kit  +     controls. The cumulative fi  ndings 
suggest a role for the stem cell factor  –  Kit interaction in neu-
trophil development in certain genetic backgrounds and/or 
when mutations in that ligand  –  receptor pair are located within 
the molecules themselves (  14, 16  ) and hence are global (i.e., 
  Kit  W  /Kit  W-v     and   Kit  Sl    /  Kit  Sl-d     mice in the rather unusual WBB6F1 
and WCBF1 backgrounds, respectively). In contrast, an alter-
ation upstream of the   Kit   gene (  17, 18  ) is associated with a 
selective defi  ciency of expression in mast cells and proba-
bly not in myeloid progenitors that populate the neutrophil 
lineage (i.e.,   Kit  W-sh     mice in the C57BL/6 background). The 
neutropenia is not the only diff  erence in the two strains, as 
  Kit  W  /Kit  W-v     but not   Kit  W-sh     mice have a macrocytic anemia 
and defi  ciency in          T cells (  7, 19  ), whereas both strains have 
defi  ciencies in melanocytes (  20  ) and interstitial cells of Cajal (  7  ). 
Because the absence of mast cells in   Kit  W-sh     mice resulted from 
a 2-cM inversion upstream of the   Kit   gene in C3H/HeJ   ×   
101/H F1 mice (  19, 21  ), it is possible that the retention of 
certain alleles from the F1 strain even after backcrossing into 
C57BL6 mice contributes to the phenotypic diff  erences of 
  Kit  W-sh     mice compared with   Kit  W  /Kit  W-v     mice. 
  Splenic, but not BM, myeloid hyperplasia in   Kit  W-sh     mice 
  As part of a general histologic assessment for tissue mast cells, 
we noted that the spleens of   Kit  W-sh     mice as compared with 
their   Kit  +     controls had a signifi  cant 2.4-fold greater number 
of CAE  +   cells with myeloid morphology (  Fig. 4 A  ) that had a 
primarily subcapsular localization and included a signifi  cantly 
greater percentage of immature forms (68   ±   7% and 16   ±   
4%, respectively;   n   = 3; P = 0.004).   Induction of synovitis 
with anti-collagen/LPS caused an increase in the splenic CAE  +   
cells in both strains that reached a signifi  cantly greater level 
in the   Kit  W-sh     mice (  Fig. 4 A  ). As measured by fl  ow   cytometry, 
cell defi  ciency by morphological and IgE-dependent func-
tional criteria. The functionally equivalent mast cell defi  ciency 
of   Kit  W-sh     and   Kit  W  /Kit  W-v     mice had already been observed 
in models of antigen-induced pulmonary infl  ammation and 
venom detoxifi  cation, with the latter refl  ecting the ability 
of mast cell carboxypeptidase A to degrade sarafotoxins in 
venom (  9  –  11  ). 
  Basal and LPS-induced elevation of circulating and tissue 
neutrophils differs in mast cell-defi  cient strains 
  Because neutrophils are essential for the generation of joint 
swelling and tissue pathology in the anti-collagen/LPS and 
anti-GPI models (  1, 12  ), we quantifi  ed the number of periph-
eral blood neutrophils in   Kit  W  /Kit  W-v     and   Kit  W-sh     mice and 
their respective   Kit  +     control strains before and 24 h after i.p. 
injection of 25   μ  g LPS, the dose used in the anti-collagen/LPS 
model. The concentration of peripheral blood neutrophils in 
7  –  9-wk-old naive   Kit  W  /Kit  W-v     mice was only one third of that 
in WBB6F1-  Kit  +     mice (  Fig. 3  ).   LPS induced a signifi  cant 
threefold increase in the concentration of peripheral blood 
neutrophils in both of these strains, and the level reached in 
  Kit  W  /Kit  W-v     mice was again only one third of that in WBB6F1-
  Kit  +     mice. Because there was no arthritis in the   Kit  W  /Kit  W-v     
strain, we compared the LPS-elicited effl   ux of peripheral blood 
neutrophils into the ear skin of   Kit  W  /Kit  W-v     and WBB6F1-  Kit  +     
mice. 24 h after intradermal (i.d.) injection of 50   μ  g LPS, there 
were signifi  cantly fewer neutrophils in the peripheral blood of 
  Kit  W  /Kit  W-v     mice compared with WBB6F1-  Kit  +     mice (0.68   ±   
0.074 vs. 1.5   ±   0.15   ×   10  3   cells per   μ  l, respectively;   n   = 9  –  11; 
P = 0.0002) and recruited into the ears (5.8   ±   0.8 vs. 13.3   ±   
1.7 neutrophils per unit length, respectively;   n   = 11  –  12; P = 
0.008). Our data confi  rm and extend the fi  ndings of Cherven-
ick and Boggs reported in 1969 (  13  ), which indicated that the 
concentration of peripheral blood neutrophils in naive 3-mo-
old   Kit  W  /Kit  W-v     mice (the youngest mice examined) was a 
  Figure 3.     Peripheral blood neutrophil concentrations in naive and 
LPS-treated mast cell  –  defi  cient and   –  suffi  cient mice. Blood samples 
were obtained from   Kit  W /Kit W-v    and   Kit  W-sh    mice and their respective control 
strains before and 24 h after i.p. injection of saline or 25     g LPS. The con-
centration of neutrophils in the samples was quantifi  ed with an automated 
cell counter. Data are expressed as mean   ±   SEM;   n   =  7 – 15  per  genotype.   2800 ANTIBODY-MEDIATED ARTHRITIS IN MAST CELL  –  DEFICIENT MICE | Zhou et al.
than in   Lilrb4  +    /  Kit  W-sh     mice (P = 0.03;   Fig. 5  ).   Histologic 
analysis of the synovial thickness in the talo-tibial articulation 
of the ankle joint at day 7 revealed a trend toward greater 
thickness in   Lilrb4    −     /  Kit  W-sh     mice compared with   Lilrb4  +    /  Kit  W-sh     
mice (71.0   ±   10 vs. 52.7   ±   6.1   μ  m, respectively;   n   = 9; P = 
0.1; the measurements were made in the same experiments 
that provided the comparison of   Kit  +     and   Kit  W-sh     mice noted 
above). Moreover, as assessed by digital image analysis of the 
loss of staining with safranin O, there was a signifi  cant approx-
imately twofold greater depletion of cartilage matrix at day 7 
in   Lilrb4    −     /  Kit  W-sh     mice compared with   Lilrb4  +    /  Kit  W-sh     mice 
(32.2   ±   6.3 vs. 17.0   ±   2.8%;   n   = 9; P = 0.04). Hence, the ex-
acerbation of these characteristics in the absence of LILRB4 
proceeds without a mast cell infl  uence, compatible with a central 
role for neutrophils. 
  To establish an absolute neutrophil requirement in the 
LILRB4-suffi   cient and -defi  cient   Kit        W-sh       strains, mice were 
  injected i.p. with anti  –  Gr-1 on days 2 and 4 of the anti-collagen/
LPS protocol, as done previously with   Lilrb4        +       and   Lilrb4          −        
mast cell  –  suffi   cient mice on the BALB/c background (  1  ). 
Treatment with anti  –  Gr-1 depleted peripheral blood neutro-
phils by   >  95% compared with untreated mice and suppressed 
clinical scores in both   Lilrb4  +    /  Kit  W-sh     (0   ±   0 vs. 6.0   ±   3, re-
spectively) and   Lilrb4    −     /  Kit  W-sh     mice (0   ±   0 vs. 9.0   ±   0) at day 7 
(  n   = 2  –  5 mice per genotype). 
  In addressing the discrepancy as to why the   Kit        W-sh       but 
not   Kit        W        /Kit        W-v       mast cell  –  defi  cient strain is fully susceptible 
to anti-collagen/LPS-induced arthritis, we confi  rmed an old 
observation that   Kit        W        /Kit        W-v       mice are neutropenic and mobi-
lize blood neutrophils poorly (  13  ). Although there are also 
defi  ciencies in other lineages in   Kit        W        /Kit        W-v       mice that are not 
present in   Kit        W-sh       mice, we have focused on the neutrophil 
because of its prominence in the model. This has recently 
been highlighted in studies of arthritis induced with Ab to 
GPI in which clinical and tissue pathology was interrupted 
when the number of neutrophils fell due to blockade of their 
continuous recruitment from blood by local generation or ac-
tion of leukotriene B  4   with inhibitors of 5-lipoxygenase or 
dispersed splenocytes from naive   Kit  +     and   Kit  W-sh     mice were 
7   ±   2 and 32   ±   7% Gr-1  +  , respectively (  n   = 4; P = 0.01; rep-
resentative histograms are presented in   Fig. 4 B  ), consistent 
with the greater number of CAE  +   myeloid cells in   Kit  W-sh     
mice. In contrast, there was no diff  erence in the number 
of CAE  +   cells in the BM of   Kit  +     and   Kit  W-sh     mice (64   ±  6.5 
and 70   ±   1.2 cells per high power fi  eld, respectively;   n   = 4). 
There was also no diff  erence in the number of BM cells re-
covered from the femurs and tibias of   Kit  +     and   Kit  W-sh     mice 
(5.4   ±   1.5 and 5.8   ±   1.4   ×   10  7  , cells/mouse, respectively;   n   = 3) 
or in the percentage of Gr-1  +   cells in the BM (72   ±   8 and 77   ±   
5%, respectively;   n   = 3  –  4). Because the BM of   Kit  W-sh     mice 
lacked these changes, and the blood level and recruitment 
of neutrophils in the joints and ears of   Kit  W-sh     mice was the 
same as in   Kit  +     mice with no increase in morphologically im-
mature myeloid cells, there was no evidence that the splenic 
  dysmyelopoiesis was a factor in the normal response to anti-
collagen/LPS-induced arthritis in mast cell  –  defi  cient   Kit  W-sh     
mice. Indeed, there was no diff  erence in   Kit  +     and   Kit  W-sh     mice 
at day 7 of the anti-collagen mAbs/LPS model in the number 
of peripheral blood neutrophils (1.9   ±   0.7 and 1.5   ±   0.5   ×   
10  3  /  μ  l, respectively;   n   = 4; P = 0.6) and neutrophils per unit 
area in the synovium (19.6   ±   6.8 and 21.2   ±   7.4 cells/unit area, 
respectively;   n   = 9; P = 0.8) and joint space (5.8   ±   1 and 8.4   ±   
2.6 cells/unit area, respectively;   n   = 9; P = 0.3) at day 7. 
  Infl  ammatory arthritis is exacerbated in   Lilrb4  -    /  Kit  W-sh     mice 
  The full infl  ammatory arthritis in   Kit  W-sh     mice aff  orded the 
opportunity to assess the potential contribution of LILRB4 in 
the absence of mast cells. The clinical scores in the   Lilrb4  +    /
  Kit  W-sh     and   Lilrb4    −     /  Kit  W-sh     on day 7 reached values of 6.1   ±   
1.4 and 8.7   ±   1.6, respectively, and the entire time course of 
clinical scores in   Lilrb4    −     /  Kit  W-sh     mice was signifi  cantly greater 
  Figure 4.     Histologic and fl  ow cytometric assessments of myeloid 
hyperplasia in the spleen of   Kit  W-sh     mice. (A) Tissue sections from naive 
mice and mice on day 7 after injection of anti-collagen/LPS were stained 
for CAE activity and counterstained with hematoxylin. The number of 
CAE  +   cells in the subcapsular region was counted in fi   ve  40 ×   fi  elds per 
sample. Data are expressed as mean   ±   SEM;   n   = 5 (naive) and   n   = 6 (day 7). 
(B) Spleen cells were stained with PE-labeled anti  –  Gr-1 or an isotype-matched 
negative control mAb, and fl  uorescence was analyzed by fl  ow cytometry.     
  Figure 5.     Anti-collagen/LPS-induced joint swelling in   Kit  W-sh    mice 
suffi  cient and defi  cient in LILRB4. Mice were injected and their clinical 
scores were determined as described in the legend for Fig. 1, except that 
1 mg of anti-collagen was used. Data are expressed as mean   ±   SEM;   n   =  9 
from three experiments.     JEM VOL. 204, November 26, 2007  2801
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local edema; 2, swelling localized to either the dorsal or ventral surface of a 
paw; 3, swelling on all aspects of a paw (  1  ). The sum of the four scores was 
defi  ned as the clinical score for each mouse. Synovial thickness was measured 
in histologic sections of the talo-tibial articulation of the ankle joint stained 
for CAE activity as described previously (  1  ). Cartilage matrix depletion was 
measured in sections stained with Safranin O as described previously (  1  ), ex-
cept that the areas of cartilage matrix depletion within the cartilaginous re-
gions were outlined in digital photomicrographs, converted to pixels with 
ImageJ software (Image Processing and Analysis in Java developed by the 
National Institutes of Health), and expressed as a percentage of the total car-
tilaginous region. Quantifi  cation of LPS-induced neutrophilia was performed 
in ear sections stained for CAE activity (  2  ). 
  IgE-dependent anaphylaxis.     For PCA in the ear, mice were injected i.d. 
in one ear with 25 ng IgE anti-DNP (SPE-7; Sigma-Aldrich) and with an 
equal volume of saline (20   μ  l) in the other ear. 20 h later, mice were injected 
i.v. with 100     g DNP-HSA (30  –  40 moles DNP/HSA; Sigma-Aldrich) in 
100     l of 1% Evans Blue dye. After 0.5 h, mice were killed, ear tissue was 
obtained with a 6-mm diameter punch, dye was extracted from the tissue by 
incubation in 200     l of formamide at 58  °  C for 48 h, the tissue was pelleted 
by centrifugation, and the dye in the supernatant was quantifi  ed spectrophoto-
metrically (  3, 29  ). For PCA in the paw, mice were injected s.c. in one hind 
paw with 75 ng IgE anti-DNP and in the other hind paw with an equal vol-
ume (10   μ  l) of saline. Mice were challenged with antigen and Evans blue, 
killed, and the paws were collected from the fur line and cut into small pieces. 
The dye was extracted as for PCA in the ear except that an extraction volume 
of 1 ml was used. For IgE-dependent systemic anaphylaxis, mice were in-
jected i.v. with 40   μ  g of rat anti  –  mouse IgE (R35-72; BD Biosciences). 
  Peripheral blood neutrophil counts and Ab-mediated depletion.   
  Blood was collected, and leukocyte counts and diff  erentials were determined 
with an automated cell counter as described previously (  1  ). For neutrophil 
depletion, mice were injected i.p. with rat anti  –  Gr-1 mAb or rat IgG2b iso-
type control mAb (  1, 12  ). 
  Flow cytometry.     Spleens were disaggregated mechanically to liberate sple-
nocytes, and the cells were incubated for 10 min at room temperature with 
ACK buff  er (155 mM NH  4  Cl, 10 mM KHCO  3  , 111     M disodium EDTA in 
Milli-Q water) to lyse erythrocytes, centrifuged, and resuspended at 10  6   cells/ml 
in HBA buff  er (calcium- and magnesium-free HBSS containing 0.1% [wt/vol] 
BSA and 0.02% [wt/vol] sodium azide). The spleen cells were incubated for 
30 min at 4  °  C with a saturating concentration of PE-labeled anti  –  Gr-1 or an 
equal concentration of isotype-matched negative control rat IgG2b mAb, 
washed in HBA buff  er twice, and analyzed for fl  uorescence intensity on a 
FACSort (Becton Dickinson Immunocytometry Systems). 
  Statistical analyses.     Data are expressed as mean   ±   SEM unless otherwise 
noted. Diff  erences in single measurements between groups of mice were 
  assessed with Student  ’  s unpaired, two-tailed   t   test. Diff  erences in the time 
courses of clinical scores were assessed with ANOVA. p-values of   <  0.05 
were defi  ned as statistically signifi  cant. 
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